Tivic Health Systems, Inc.
TIVC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.37 | -0.00 | 0.18 | -0.73 |
| FCF Yield | -0.34% | -604.49% | -8.49% | -2.44% |
| EV / EBITDA | -318.44 | 0.20 | -10.30 | -32.82 |
| Quality | ||||
| ROIC | -223.31% | -208.79% | -233.59% | -39.83% |
| Gross Margin | 0.26% | 24.40% | 16.25% | -11.06% |
| Cash Conversion Ratio | 1.01 | 1.03 | 0.88 | 0.66 |
| Growth | ||||
| Revenue 3-Year CAGR | -24.88% | 0.29% | 28.86% | 40.55% |
| Free Cash Flow Growth | 33.65% | 3.37% | -59.12% | -85.40% |
| Safety | ||||
| Net Debt / EBITDA | 0.38 | 0.38 | 0.30 | 1.85 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -3.09 |
| Efficiency | ||||
| Inventory Turnover | 2.44 | 1.18 | 1.79 | 3.02 |
| Cash Conversion Cycle | 123.30 | 71.66 | -87.73 | -72.67 |